Cybin Inc. (OTCMKTS:CLXPF - Get Free Report) shares rose 1.9% on Wednesday . The company traded as high as $10.00 and last traded at $9.77. Approximately 167,086 shares traded hands during trading, a decline of 70% from the average daily volume of 551,962 shares. The stock had previously closed at $9.59.
Cybin Stock Up 1.2 %
The firm has a market capitalization of $1.48 billion and a price-to-earnings ratio of -41.58. The business's 50-day simple moving average is $9.76 and its two-hundred day simple moving average is $6.72.
Cybin Company Profile
(
Get Free Report)
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Articles
Before you consider Cybin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cybin wasn't on the list.
While Cybin currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
